This is an investigator-initiated, multicenter, randomized, crossover design study to compare the therapeutic effectiveness of split-mixed BID insulin using human regular and ultralente insulin or pork regular and NPH. All subjects (20 from each of 5 centers; 100 in total) must have IDDM, be 4-11 years old, and be prepubertal. Each will be treated for six months with each regimen in randomized sequence. Glycemic control and hypoglycemia rates will be assessed.
Showing the most recent 10 out of 497 publications